Apogee Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $130 |
Gross Profit | -400 | -400 | -207 | 65 |
EBITDA | -64,559 | -72,766 | -62,889 | -75,805 |
EBIT | -64,959 | -73,165 | -63,096 | -75,881 |
Net Income | -65,021 | -66,096 | -55,339 | -67,218 |
Net Change In Cash | 0 | 0 | 0 | 130 |
Free Cash Flow | -54,255 | -62,797 | -52,794 | -67,713 |
Cash | 107,914 | 124,192 | 106,916 | 141,789 |
Basic Shares | 58,773 | 58,428 | 58,195 | 55,193 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -189 | ||
EBITDA | -216,681 | -74,967 | -39,785 |
EBIT | -216,870 | -83,985 | -64,247 |
Net Income | -182,146 | -83,985 | -39,785 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -172,326 | -74,928 | -16,427 |
Cash | 141,789 | 118,316 | 151,890 |
Basic Shares | 55,193 | 50,655 | 50,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.11 |
2025-06-30 | -$1.13 |
2025-03-31 | -$0.95 |
